Therapeutic potential of inhaled p38 mitogen-activated protein kinase inhibitors for inflammatory pulmonary diseases

Author： Chopra Puneet Kanoje Vijay Semwal Arvind Ray Abhijit

ISSN： 1354-3784

Source： Expert Opinion on Investigational Drugs, Vol.17, Iss.10, 2008-10, pp. : 1411-1425

Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.

Previous Menu Next

Abstract

Related content

Structure-Activity Relationships of p38 Mitogen-Activated Protein Kinase Inhibitors

Mini Reviews in Medicinal Chemistry, Vol. 5, Iss. 9, 2005-01 ,pp. : 857-868

Bentham Science Publishers

Access to resources Recommend Favorite

Anti-inflammatory potency of FR167653, a p38 mitogen-activated protein kinase inhibitor, in mouse models of acute inflammation

By Nishikori T. Irie K. Suganuma T. Ozaki M. Yoshioka T.

European Journal of Pharmacology, Vol. 451, Iss. 3, 2002-09 ,pp. : 327-333

Elsevier

Access to resources Recommend Favorite

p38α mitogen-activated protein kinase inhibitors, a patent review (2005 – 2011)

By Fischer Stefan Koeberle Solveigh C Laufer Stefan A

Expert Opinion on Therapeutic Patents, Vol. 21, Iss. 12, 2011-12 ,pp. : 1843-1866

Informa Healthcare

Access to resources Recommend Favorite

p38 Mitogen-Activated Protein Kinase Inhibitors: A Review on Pharmacophore Mapping and QSAR Studies

Current Topics in Medicinal Chemistry, Vol. 13, Iss. 9, 2013-05 ,pp. : 1015-1035

Bentham Science Publishers

Access to resources Recommend Favorite

p38 Mitogen-Activated Protein Kinase (MAPK) in Rheumatoid Arthritis

Mini Reviews in Medicinal Chemistry, Vol. 6, Iss. 8, 2006-08 ,pp. : 867-874

Bentham Science Publishers

Access to resources Recommend Favorite